J. Stastny
University of Vienna
34 Papers
587 Citations
J. Stastny is an academic researcher from University of Vienna. The author has contributed to research in topics: Light therapy & Serotonin transporter. The author has an hindex of 17, co-authored 34 publications. Previous affiliations of J. Stastny include Medical University of Vienna.
Chat about Author
Papers
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism
Matthäus Willeit,J. Stastny,Walter Pirker,Nicole Praschak-Rieder,Alexander Neumeister,Susanne Asenbaum,Johannes Tauscher,Karoline Fuchs,Werner Sieghart,Kurt Hornik,Harald N. Aschauer,Thomas Brücke,Siegfried Kasper +12 more
TL;DR: The data provide no evidence for in vivo functional regulation of 5- HTTLPR availability by 5-HTTLPR in the thalamus-hypothalamus and mesencephalon-pons of healthy subjects.
133
Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls.
Alexander Neumeister,Matthäus Willeit,Nicole Praschak-Rieder,Susanne Asenbaum,J. Stastny,E. Hilger,Walter Pirker,Anastasios Konstantinidis,Siegfried Kasper +8 more
TL;DR: These data suggest reductions in the availability of striatal DAT binding sites in untreated symptomatic depressed SAD patients, providing evidence that brain dopaminergic systems may be involved in the pathophysiology of SAD.
118
Receptor and Transporter Imaging Studies in Schizophrenia, Depression, Bulimia and Tourette's Disorder—Implications for Psychopharmacology-
Siegfried Kasper,Johannes Tauscher,Matthäus Willeit,Mara Stamenkovic,Alexander Neumeister,B. Küfferle,Christian Barnas,J. Stastny,Nicole Praschak-Rieder,Lukas Pezawas,Martina de Zwaan,S. Quiner,Walter Pirker,Susanne Asenbaum,Ivo Podreka,Thomas Brücke +15 more
TL;DR: It is demonstrated that atypical antipsychotics have a dose-dependent lower striatal D2 receptor occupancy rate compared with typical neuroleptics, paralleling the more favourable extrapyramidal side effects of atypicals antipsychotic side effects.
93
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy.
Dietmar Winkler,Edda Pjrek,Nicole Praschak-Rieder,Matthäus Willeit,Lukas Pezawas,Anastasios Konstantinidis,J. Stastny,Siegfried Kasper +7 more
TL;DR: Treatment with BLT normalizes disturbed activity patterns and restores circadian rhythms in SAD patients and might also stabilize the circadian rhythm in nondepressed individuals during the fall-winter season.
85
Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder
Nicole Praschak-Rieder,Matthäus Willeit,Alexander Neumeister,E. Hilger,J. Stastny,N. Thierry,Elisabeth Lenzinger,Siegfried Kasper +7 more
TL;DR: Preliminary evidence for a high point prevalence rate of PMDD in premenopausal females with SAD is provided, and an additional diagnosis of PM DD has an impact on the clinical outcome and the response to bright light therapy in female patients with S AD.
55